2nd November 2018
RPS welcomes legalisation of cannabis-derived medicinal products
From 1st November 2018 it is now legal for clinicians on the General Medical Council’s specialist register to prescribe cannabis-derived medicinal products.
Commenting on the transfer of these products from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations 2001, President of the Royal Pharmaceutical Society Ash Soni said:
“This is a great step forward for patients whose conditions will be improved by better access to cannabis-based medicinal products”.
Read on here:
